Real-World Effectiveness and Safety of Saccharomyces boulardii CNCM I-745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp-EuReg).

Helicobacter · 2026 · PMC13043801 · PMID 41923280

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

showed a trendp ≈0.05actually significant

90%; p < 0.05; OR = 2.32; 1.34–4.03; p < 0.05) (Table 3b ) and showed a trend toward higher effectiveness with Triple‐AL (92.5% vs. 86%; p ≈0.05).

also in 33,225 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.